Abstract
Background:
Continuous glucose monitoring (CGM) devices, with their 1-5 min measurement interval, allow blood glucose (BG) concentration dynamics to be captured more frequently and less invasively than traditional BG measures. One cohort CGM could provide insight is athletes. This study investigates what impact their heightened energy expenditure and dietary intake may have on their ability to achieve optimal BG.
Methods:
Ten subelite athletes (resting HR<60 bpm, training>6 hrs per week) were recruited. Two Ipro2 CGM devices (Medtronic Minimed, Northridge, CA) were inserted into the abdomen and remained in place for ~6 days. Time in band was calculated as the percentage of CGM BG measurements with in the 4.0-6.0 mmol/L. Fasting glucose was calculated using CGM calibration BG measurements and postprandial glucose response was also calculated using the CGM values.
Results:
4/10 athletes studied spent more than 70% of the total monitoring time above 6.0 mmol/L even with the 2-hour period after meals is excluded. Fasting BG was also in the ADA defined prediabetes range for 3/10 athletes. Only 1 participant spent substantial time below 4.0 mmol/L which was largely due to significantly lower energy intake compared to recommendations.
Conclusions:
Contrary to expectations high BG appears to be more of a concern for athletes then low BG even in those with the highest energy expenditure and consuming below the recommended carbohydrate intake. This study warrants further investigation on the recommended diets and the BG of athletes to better determine the causes and impact of this hyperglycemia on overall athlete health.
Keywords: continuous glucose monitoring, hyperglycemia, athletes, exercise, fasting blood glucose, postprandial glucose
The World Health Organization (WHO) defines normal glycemia as fasting glucose less than 6.1 mmol/L and recommends that glucose be <7.8 mmol/L 2 hours after a 75 g oral glucose tolerance test (OGTT) test.1 The American Diabetes Association (ADA) considers those with a fasting glucose of 5.6-6.9 mmol/L and blood glucose (BG) > 7.8 -11.0 mmol/L after an OGTT at increased risk of diabetes.2 However, as the WHO guidelines explain, there is no definitive cut off for “normoglycemia.”1
Continuous glucose monitoring (CGM) devices, with their 1-5 minute measurement interval, allow BG concentration dynamics to be captured far more frequently and less invasively than traditional BG measures. CGM devices typically consist of a small pager-like monitoring device that receives a signal from a sensor inserted into the subcutaneous layer. The sensor creates a signal using the glucose oxidase reaction and produces a current proportional to the glucose concentration in the surrounding interstitial fluid. The signal is converted into a BG value by using calibration BG measurements, which are entered into the monitor by the user every ~6-8 hrs.
These devices are primarily designed for use in individuals with type 1 and type 2 diabetes to aid BG regulation and are well studied in this cohort.3,4 However, because of the increased measurement frequency and reduced invasiveness they have recently been applied to other cohorts, such as intensive care patients and neonates, with varying success.5-12 Another, perhaps overlooked, cohort where the more intensive metabolic monitoring provided by CGM may be beneficial is athletes.
Athletes are traditionally encouraged to consume a diet rich in carbohydrates to ensure adequate glycogen stores and improve performance.13-15 Physical training is known to improve insulin sensitivity, both immediately postexercise and through multiple long-term adaptations in glucose transport and metabolism.16 However in contrast, strenuous exercise is known to increase circulating concentrations of catecholamines, such as adrenalin and noradrenaline, to near pathological levels,17,18 resulting in hyperglycemia and hyperinsulinemia post–intense exercise.17,19,20
This study aims to use the CGM BG profiles and dietary habits of subelite athletes to investigate if this cohort is achieving optimal BG levels during normal free living and training. The CGM data provide a unique insight in to the day to day BG levels of Athletes that could not be achieved without the application of this technology. In particular, it asks what impact their increased insulin sensitivity, heightened energy expenditure and increased exposure to stress hormones have on their BG levels.
Methods
Ten fit, healthy subelite athletes (resting HR <60 bpm) were recruited under informed written consent for a study into optimal athlete nutrition (henceforth referred to as athletes). Table 1 summarizes the cohort demographics. All subjects regularly trained > 6 hours per week in a range of endurance based sports, predominantly running and cycling. Participants were free living during the monitoring period and did not have tailored nutritional programs from this study or an existing coach. The research procedures and use of data were approved by the University of Canterbury Human Ethics Committee.
Table 1.
Number | 10 |
---|---|
Age (years) | 28 [23, 37] |
Gender (M/F) | 7/3 |
BMI (kg/m2) | 22 [21, 24] |
Resting HR (bpm) | 55 [53, 56] |
VO2max (mL/kg/min) | 46 [39, 59] |
Data are presented as median [interquartile range] where appropriate.
Two Ipro2 and 1 Guardian Real-time CGM devices (Medtronic Minimed, Northridge, CA, USA) were inserted into the abdomen of each athlete ~24 hours prior to the first ‘fasted exercise test’. The CGM device remained in each subject for 4-6 days. For all athletes, the Ipro CGM devices were both inserted in to the left side of the abdomen and the Guardian in the right side. These devices are referred to as sensor 1 (SG1), the lower left abdomen sensor, sensor 2 (SG2), the upper-left abdomen sensor, and the real-time sensor in the right abdomen sensor (SGrealtime). Figure 1 shows these locations which are typical for these devices. The Guardian real-time data were not used in this analysis. Two Ipro2 sensors were worn to provide redundancy in case of sensor failure, which is not immediately apparent with these retrospective devices.
During the ~6 days of CGM per athlete:
BG was measured 4 times per day prior to meals, thus including morning fasting, and sleeping. These measurements were used to calibrate the device (calibration BG)
All meals and snacks were recorded (self-reporting) and carbohydrate, sugar, fiber, protein and fat intake was calculated.
Any exercise was also recorded (self-reporting) and energy expenditure estimated.
A fasted exercise test was carried out on Day 2, as shown in Figure 2.
Calibration BG measurements were taken using capillary finger stick measurements and the Abbott Optimum Xceed (Abbott Diabetes Care, Alameda, CA) glucometer. The Abbott device has reported error of 5-10%.9,21-23 A body composition analysis was undertaken by 8 of the 10 participants prior to the fasting test using a body composition analyzer (InBody230, InBody Bldg, Seoul, Korea).
Analysis
Sensor glucose (SG) data from measured CGM traces of the 2 Ipro2 devices were analyzed. These devices have shown to have very good accuracy and sensor agreement in active individuals.8,24 The 2 signals were averaged at each time step for the time period they were worn to provide a single, reliable trace of BG. For Ath04, Ath09, and Ath10 only 1 CGM trace was available due to sensor failure.
For each athlete, the cumulative distribution of BG data was analyzed for the entire 5-6 days of monitoring, and reanalyzed with the 2-hour period following any meal or snack removed. Time in band was calculated as the percentage of SG with in the 4.0-6.0 mmol/L during the 2 different monitoring periods. Although a consensus has yet to be reached on what normal glucose levels, intensive insulin therapy studies show achieving higher time in this band results in improved patient outcomes25-27 and it lies below typical thresholds for diabetes diagnosis.1,2 Many studies have also demonstrated the linearly increasing risks associated with hyperglycemia, regardless of diabetes status, with lower limits between 4.0 and 6.0 mmol/L.1,28-33
The average carbohydrate, sugar, and fiber intake (g/day) while using CGM were calculated. First, daily caloric intake was calculated using basal metabolic rate (BMR) as estimated by the body composition analysis. For 2/10 athletes, Ath02 and Ath03, body composition analysis results were not available. Therefore, BMR was estimated using the standard equations34 that take in to account height, weight, and age. This BMR was then multiplied by an activity factor35 considering the amount of exercise undertaken by the athlete during the monitoring period. This process and relating caloric requirements are shown in Table 2.
Table 2.
Subject | BMR (kcal) | Average exercise (min/day) | Activity factor | Calories required (kcal/d) | Average calorie intake per day (kcal/d) |
---|---|---|---|---|---|
Ath01 | 1342 | 84 | 1.9 | 2550 | 2147 |
Ath02 | 1868a | 41 | 1.7 | 3176 | 3864 |
Ath03 | 1927* | 68 | 1.9 | 3661 | 1877 |
Ath04 | 1770 | 93 | 2.1 | 3717 | 3555 |
Ath05 | 1680 | 158 | 2.3 | 3864 | 2568 |
Ath06 | 1694 | 28 | 1.5 | 2541 | 2654 |
Ath07 | 1780 | 20 | 1.5 | 2670 | 2838 |
Ath08 | 1895 | 24 | 1.5 | 2843 | 4144 |
Ath09 | 1379 | 102 | 2.1 | 2896 | 2726 |
Ath10 | 1400 | 42 | 1.7 | 2380 | 2363 |
Values were calculated using standard equations rather than a body composition analysis.
US dietary guidelines36 recommend 45-65% of total calorie intake be from carbohydrates and the recommended amount of added sugars is also related to calorie level in these guidelines. Added sugar content of food consumed during the monitoring period was calculated using the US Department of Agriculture (USDA) database.37 If the added sugar content was not available from the database it was assumed to be zero, providing an overall conservative estimate.
Fasting blood glucose (FBG) was calculated as the median value of the calibration measurements taken prior to breakfast over the 5-6 days of CGM monitoring. Fasting plasma insulin (FPI) was determined by the first plasma insulin measurement taken prior to starting the fasted exercise test on Day 2 (Figure 2). Fasting insulin secretion (FIS) was calculated from the initial C-peptide measurement taken prior to starting the fasted exercise test using the method of Van Cauter et al38 assuming steady-state, as subjects were fasted.
Postprandial glucose response (PPGR) was calculated as the incremental area under the BG curve after a meal.39 Only the area above the starting glucose value was considered. PPGR was only considered for meals that had greater than 30 g of carbohydrate, and where there was no meal of greater than 15 g carbohydrate in the 2 hours prior to or after this meal. If meals were consumed within 15 minutes then carbohydrate content was combined and the 2-hour area under the curve considered from the start of the second meal. Postprandial glucose (PPG) was the glucose value recorded 2 hours after a meal under the same conditions as above.
Results
Individual SG profiles are shown in Figure 3 and Figure 4. These profile highlight the very unique response of each individual to exercise and carbohydrates. Ath02 and Ath04 both show very little variation in SG but Ath02 SG is centered on a higher glucose value resulting in more time out of the 4.0-6.0 mmol/L. Other subjects such as Ath03 and Ath09 show a large variation in SG, once again centered on different glucose levels resulting in Ath03 displaying the most hypoglycemia and Ath09 displaying the most hyperglycemia. Also individual plots for each SG profile can be found in the supplementary material accompanying this article. These plots show both SG profiles and the resulting averaged SG.
In Figure 5 it is further evident participants spend a significant amount of time outside the normoglycemic 4.0-6.0 mmol/L range. Once meals are removed, in the bottom plot, there is a distinct separation between 4/10 of the subjects (Ath05, 07, 08, 09) who have less than 30% time in the 4.0-6.0 mmol/L. In contrast, the remaining 6/10 participants achieve over 85% time in the desired 4.0-6.0 mmol/L range, which is clear when comparing the distributions.
All but 4 participants consumed on average an amount of carbohydrate that was between 45 and 65% of their recommended daily calorie intake. Ath03, Ath05, and Ath09 did not reach the minimum recommended amount of carbohydrate. Ath08 consumed more than 65% of their recommended intake as carbohydrate. All participants achieved their recommended fiber intake of >25 g. Some participants, such as Ath07 and Ath08, have a very low fiber to sugar ratio and nearly double the recommended intake of added sugars (Figure 6). Ath03 consumed on average ~150 g of carbohydrate less than the lower recommended limit, 1770 kcal less than required (Table 2) and was the only participant to demonstrate a significant amount time below 4.0 mmol/L.
Table 3 shows Ath05, Ath07 and Ath09 have elevated fasting glucose within the prediabetes range 5.6-6.9 mmol/L suggested by the ADA. However, none of the subjects met the prediabetes criteria of PPG > 7.8 mmol/L. Although this criteria is based on the BG 2 hours after a 75 g glucose tolerance test rather than after an uncontrolled meal. The mean PPGR ranges from 0.2 to 2.0 mmol/L.hr displaying a wide range intra and inter of carbohydrate sensitivity. High PPGR did not necessarily correlate with time out side of the 4.0-6.0 mmol/L band.
Table 3.
Subject | Sex | Age | BMI | PBF (%) | FFM (kg) | FBG (mmol/L) | FPI (mU/L) | FIS (mU/L.min) | TIB-MR (%) | Mean PPGR (mmol/L.hr) | Mean PPG (mmol/L) | Exercise (min/day) | VO2max (mL/kg/min) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ath01 | F | 23 | 21.6 | 25.3 | 45 | 5.2 | 9.0 | 1319 | 86.6 | 1.1 | 6.1 | 84 | 39 |
Ath02 | M | 23 | 21.9 | — | — | 5.1 | 6.3 | 913 | 90.7 | 0.5 | 6.0 | 41 | 60 |
Ath03 | M | 50 | 26.4 | — | — | 4.7 | 11.8 | 1878 | 76.1 | 1.9 | 6.0 | 68 | 39 |
Ath04 | M | 23 | 20.4 | 5.1 | 64.8 | 4.6 | 6.5 | 832 | 99.2 | 0.5 | 5.5 | 93 | 67 |
Ath05 | M | 28 | 24.2 | 14.1 | 60.6 | 6.0 | 6.3 | 820 | 30.7 | 0.9 | 6.8 | 158 | 59 |
Ath06 | M | 36 | 22.4 | 15.5 | 63.3 | 4.4 | 8.3 | 1844 | 94.3 | 1.2 | 5.9 | 28 | 59 |
Ath07 | M | 37 | 26.0 | 19.7 | 65.3 | 6.7 | 10.5 | 1553 | 23.9 | 1.1 | 7.1 | 20 | 42 |
Ath08 | M | 22 | 24.5 | 13.2 | 70.6 | 5.5 | 11.0 | 1550 | 31.7 | 0.2 | 5.5 | 24 | 37 |
Ath09 | F | 37 | 21.1 | 17.8 | 46.7 | 6.0 | 6.0 | 936 | 9.7 | 2.0 | 7.4 | 102 | 47 |
Ath10 | F | 27 | 22.2 | 28.3 | 47.7 | 5.2 | 9.5 | 1344 | 86.6 | 1.0 | 6.7 | 42 | 44 |
FBG, fasting blood glucose; FFM, fat free mass; FIS, fasting insulin secretion; FPI, fasting plasma insulin; Maxppg, maximum blood glucose value reached after a meal; PBF, percentage body fat; PPG, blood glucose value 2 hours after a meal; PPGR, postprandial glucose response; TIB-MR, time in band, with meals removed. Body composition analysis results were not available for Ath02 and Ath03, hence PBF and FFM values are missing.
Discussion
Physical training is known to improve insulin sensitivity, both immediately postexercise (up to 2 hrs) and through multiple adaptations in glucose transport and metabolism.16 Therefore, it could be expected high BG would not be frequently seen in athletes and low BG would be of greater concern due to increased energy expenditure. However, this hypothesis does not appear to be the case in the data we have collected.
In particular, 4/10 subjects spent more than ~70% of the total monitoring period with SG > 6.0 mmol/L even with the 2-hour period after meals removed. Only 1 athlete experienced a significant time below 4.0 mmol/L and this behavior appears largely due to a considerably decreased calorie intake compared to recommended guidelines.
Ath09 and Ath05 undertook the most exercise during the monitoring period, averaging 102 and 158 min/day respectively. This high training load could have contributed to the low time in the 4.0-6.0 mmol/L band, as exercise is known to increase BG and induce hyperglycemia and hyperinsulinemia as a result of this catecholamine response.17,19,20 Both subjects have the lowest FPI and insulin secretion recorded suggesting efficient glucose uptake. In addition, both achieved VO2max values that put them in the excellent category based on their gender and age.
Ath07 and Ath08 carried out the least amount of exercise during the monitoring period only averaging 20 and 24 min/day of exercise, while over consuming added sugars1 and Ath08 over consuming on the recommended carbohydrate intake. Lowering physical activity is known to impact the glycemic control of healthy individuals and the increased insulin sensitivity witnessed due to training wanes with 5 days of detraining.16,40-42 The large amount of time spent out of band by Ath07 and Ath08 is likely to be attributed to these diet and lifestyle choices. This conclusion is supported by Ath07 and Ath08 showing the highest FPI levels and FIS and only achieving average or above average category VO2max levels based on gender and age.
An individual’s tolerance of carbohydrate is highly variable and is related to a number of factors including age and genetics.43,44 A differing ability to tolerate carbohydrates in this cohort is demonstrated with the wide range of cohort values of mean PPGR and mean PPG, 0.2-2.0 mmol/L.h and 5.5-7.4 mmol/L respectively. Also PPGR and PPG do not necessarily correlate with time in band or FBG. A subject can achieve good overall control or even experience low BG, such as Ath03, but still demonstrate a high mean PPGR indicating a high sensitivity to carbohydrates. A subject like Ath09 also appears to have a very high sensitivity to carbohydrates achieving high PPGR and low time in band while under consuming on the recommended carbohydrate intake. However, a subject like Ath04 displays a very high tolerance of carbohydrates, achieving the greatest time in band and very low PPGR, while still over consuming added-sugars. It is interesting to note that normalizing results by grams of carbohydrate consumed did not change the trends seen.
Athletes are traditionally encouraged to consume high carbohydrate diets to replenish muscle glycogen stores and improve performance, with a particular focus on postexercise carbohydrate consumption.13-15 However, this advice may be negatively impacting the blood sugar levels of athletes predisposed to have a low tolerance of carbohydrates. In addition it is unlikely that low BG in day to day life is a real concern for athletes, unless they are significantly under consuming calories. Hence, the potential for a more personalized nutrition plan aided by CGM to optimize the BG levels during different phases of athletes training is highlighted by these results.
This study warrants further investigation on the recommend diets and the BG levels of athletes, in particular those in the subelite category studied here. Subelite athletes are unlikely to have the same nutritional and dietary support from trained professionals as elite athletes. Hence, their nutritional intakes are more perhaps likely to be suboptimal, as demonstrated in this study.
Limitations
This study is limited by the small cohort size. However, this initial pilot investigation has highlighted some interesting points where there is potential to optimize an athlete’s diet. Hence, it has raised questions where further studies are thus justified.
A second limitation is that activity was only monitored by self-reporting in future studies it would be much better to use a specific activity monitoring device to capture energy expenditure more accurately. Equally, activity could be directly controlled in a more homogenous cohort, in a more strictly controlled study than this pilot investigation.
Conclusion
Physical training is known to significantly increase insulin sensitivity and improve PPG and PPGR. Therefore, it could be expected sustained high BG during free living would not be frequently seen in athletes and low BG would be of greater concern due to increased energy expenditure. However, this hypothesis does not appear to be the case in the data we have collected. When the SG profiles of 10 trained, subelite athletes were analyzed over a 6 day monitoring period 4/10 athletes studied spent more than 70% of the total monitoring time above 6 mmol/L even with the 2-hour period after meals removed. FBG was also in the range of prediabetes for 3/10 athletes as defined by the ADA. Only 1 participant spent substantial time below 4 mmol/L and this was largely due to a significantly lower overall calorie intake compared to recommendations. A differing ability to tolerate carbohydrates in this cohort is demonstrated with the wide range of cohort values of mean PPGR and mean PPG, 0.2-2.0 mmol/L.h and 5.5-7.4 mmol/L respectively. Therefore, a diet rich in carbohydrates may not be beneficial in some athletes, especially as low BG is unlikely to be of concern to an athlete consuming adequate calorie intake. This study provides a unique insight in to the day to day glucose levels of athletes that could only be achieved through the use of CGM devices highlighting the need for further investigation on the recommend diets of athletes to better determine the causes and impact of the hyperglycemia seen on health and performance.
Supplementary Material
Footnotes
Abbreviations: ADA, American Diabetes Association; BG, blood glucose; CGM, continuous glucose monitoring; FBG, fasting blood glucose; FFM, fat free mass; FIS, fasting insulin secretion; FPI, fasting plasma insulin; OGTT, oral glucose tolerance test; PBF, percentage body fat; PPG, postprandial glucose; PPGR, postprandial glucose response; SG, sensor glucose; TIB, time in band; T2DM, type 2 diabetes; WHO, World Health Organization.
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by an eTIME IRSES EU FP7 #318943 grant, University of Canterbury doctoral scholarship, and the Sadie Balkind Scholarship.
Supplemental Material: The supplementary material is available at http://dst.sagepub.com/supplemental
References
- 1. World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Geneva, Switzerland: World Health Organization; 2006. [Google Scholar]
- 2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Gandhi GY, Kovalaske M, Kudva Y, et al. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol. 2011;5(4):952-965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Hoeks LB, Greven WL, de Valk HW. Real-time continuous glucose monitoring system for treatment of diabetes: a systematic review. Diabet Med. 2011;28(4):386-394. [DOI] [PubMed] [Google Scholar]
- 5. Chee F, Fernando T, van Heerden PV. Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Trans Inf Technol Biomed. 2003;7(1):43-53. [DOI] [PubMed] [Google Scholar]
- 6. Holzinger U, Warszawska J, Kitzberger R, et al. Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care. 2010;33(3):467-472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Brunner R, Kitzberger R, Miehsler W, et al. Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients. Crit Care Med. 2011;39(4):659-664. [DOI] [PubMed] [Google Scholar]
- 8. Thomas F, Pretty CG, Signal M, et al. Accuracy and performance of continuous glucose monitors in athletes. IFAC-PapersOnLine. 2015;48(20):1-6. [Google Scholar]
- 9. Signal M. Continuous glucose monitoring and tight glycaemic control in critically ill patients in bioengineering. Canterbury, England: University of Canterbury; 2013. [Google Scholar]
- 10. Signal M, Pretty CG, Chase JG, et al. Continuous glucose monitors and the burden of tight glycemic control in critical care: can they cure the time cost? J Diabetes Sci Technol. 2010;4(3):625-635. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Beardsall K, Ogilvy-Stuart A, Ahluwalia J, et al. The continuous glucose monitoring sensor in neonatal intensive care. Arch Dis Child. 2005;90(4):F307-F310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Harris DL, Battin MR, Weston PJ, et al. Continuous glucose monitoring in newborn babies at risk of hypoglycemia. J Pediatr. 2010;157(2):198-202. [DOI] [PubMed] [Google Scholar]
- 13. International Olympic Committee. Nutrition for Athletes. Lausanne, Switzerland: International Olympic Committee; 2010. [Google Scholar]
- 14. Position of the American Dietetic Association, Dietitians of Canada, and the American College of Sports Medicine: nutrition and athletic performance. J Am Diet Assoc. 2000;100(12):1543-1556. [DOI] [PubMed] [Google Scholar]
- 15. Jacobs KA, Sherman WM. The efficacy of carbohydrate supplementation and chronic high- carbohydrate diets for improving endurance performance. Int J Sport Nutr. 1999;9(1):92-115. [DOI] [PubMed] [Google Scholar]
- 16. Borghouts LB, Keizer HA. Exercise and insulin sensitivity: a review. Int J Sports Med. 2000;21(1):1-12. [DOI] [PubMed] [Google Scholar]
- 17. Bloom SR, Johnson RH, Park DM, et al. Differences in the metabolic and hormonal response to exercise between racing cyclists and untrained individuals. J Physiol. 1976;258(1):1-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Rehrer NJ, Brouns F, Beckers EJ, et al. Physiological changes and gastro-intestinal symptoms as a result of ultra-endurance running. Eur J Appl Physiol Occup Physiol. 1992;64(1):1-8. [DOI] [PubMed] [Google Scholar]
- 19. Ivy JL, Katz AL, Cutler CL, et al. Muscle glycogen synthesis after exercise: effect of time of carbohydrate ingestion. J Appl Physiol. 1988;64(4):1480-1485. [DOI] [PubMed] [Google Scholar]
- 20. Marliss EB, Vranic M. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes. 2002;51(suppl 1):S271-S283. [DOI] [PubMed] [Google Scholar]
- 21. Abbott. Abbott Optium test-strip packet insert. 2010.
- 22. Brunner R, Kitzberger R, Miehsler W, et al. Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients. Crit Care Med. 2011;39(4):659-664. [DOI] [PubMed] [Google Scholar]
- 23. Thomas F, Pretty CG, Shaw GM, et al. Glucometer performance in the intensive care unit. Paper presented at: 14th Annual Diabetes Technology Meeting; 2014; Bethesda, MD. [Google Scholar]
- 24. Bailey TS, Ahmann A, Brazg R, et al. Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor. Diabetes Technol Ther. 2014;16(5):277-283. [DOI] [PubMed] [Google Scholar]
- 25. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79(8):992-1000. [DOI] [PubMed] [Google Scholar]
- 26. Chase JG, Shaw G, Le Compte A, et al. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit Care. 2008;12(2):R49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Van den Berghe G, Wouters P, Weekers W, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-1367. [DOI] [PubMed] [Google Scholar]
- 28. Brunner EJ, Shipley MJ, Witte DR, et al. Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care. 2006;29(1):26-31. [DOI] [PubMed] [Google Scholar]
- 29. Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293(2):194-202. [DOI] [PubMed] [Google Scholar]
- 30. Kijak E, Foust G, Steinman R. Relationship of blood sugar level and leukocytic phagocytosis. South Calif Dent Assn. 1964;32:349-351. [Google Scholar]
- 31. Levitan EB, Song Y, Ford ES, et al. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med. 2004;164(19):2147-2155. [DOI] [PubMed] [Google Scholar]
- 32. Nishida T, Tsuji S, Tsuji M, et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol. 2006;101(1):70-75. [DOI] [PubMed] [Google Scholar]
- 33. Tirosh A, Shai I, Tekes-Manova D, et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med. 2005;353(14):1454-1462. [DOI] [PubMed] [Google Scholar]
- 34. Harris JA, Benedict FG. A biometric study of human basal metabolism. Proc Natl Acad Sci USA. 1918;4(12):370-373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Black AE. Critical evaluation of energy intake using the Goldberg cut-off for energy intake: basal metabolic rate. A practical guide to its calculation, use and limitations. Int J Obes Related Metab Disord. 2000;24(9). [DOI] [PubMed] [Google Scholar]
- 36. US Department of Agriculture. Scientific Report of the 2015 Dietary Guidelines Advisory Committee. Washington, DC: US Department of Agriculture; 2015. [Google Scholar]
- 37. US Department of Agriculture. Food-A-Pedia. Washington, DC: US Department of Agriculture; 2015. [Google Scholar]
- 38. Van Cauter E, Mestrez F, Sturis J, et al. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41(3):368-377. [DOI] [PubMed] [Google Scholar]
- 39. Wolever TM, Jenkins DJ. The use of the glycemic index in predicting the blood glucose response to mixed meals. Am J Clin Nutr. 1986;43(1):167-172. [DOI] [PubMed] [Google Scholar]
- 40. Mikus CR, Oberlin DJ, Libla JL, et al. Lowering physical activity impairs glycemic control in healthy volunteers. Med Sci Sports Exerc. 2012;44(2):225-231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Heath G, Gavin JR, Hinderliter JM, et al. Effects of exercise and lack of exercise on glucose tolerance and insulin sensitivity. J Appl Physiol. 1983;55(2):512-517. [DOI] [PubMed] [Google Scholar]
- 42. Mikines KJ, Sonne B, Tronier B, et al. Effects of training and detraining on dose-response relationship between glucose and insulin secretion. Am J Physiol Endocrinol Metab. 1989;256(5):E588-E596. [DOI] [PubMed] [Google Scholar]
- 43. Zeevi D, Korem T, Zmora N, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163(5):1079-1094. [DOI] [PubMed] [Google Scholar]
- 44. Vrolix R, Mensink RP. Variability of the glycemic response to single food products in healthy subjects. Contemp Clin Trials. 2010;31(1):5-11. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.